Lawrence E. Crane

Array ( [id] => 900566 [patent_doc_number] => 07339053 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-04 [patent_title] => '4′-C-substituted-2-haloadenosine derivative' [patent_app_type] => utility [patent_app_number] => 11/087588 [patent_app_country] => US [patent_app_date] => 2005-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 13697 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/339/07339053.pdf [firstpage_image] =>[orig_patent_app_number] => 11087588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7051497 [patent_doc_number] => 20050187384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Process for the preparation of 2\'-halo-beta-L-arabinofuranosyl nucleosides' [patent_app_type] => utility [patent_app_number] => 11/086545 [patent_app_country] => US [patent_app_date] => 2005-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12368 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20050187384.pdf [firstpage_image] =>[orig_patent_app_number] => 11086545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4552906 [patent_doc_number] => 07820637 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-26 [patent_title] => 'Use of 5′-methylthioadenosine (MTA) in the prevention and/or treatment of autoimmune diseases and/or transplant rejection' [patent_app_type] => utility [patent_app_number] => 11/908697 [patent_app_country] => US [patent_app_date] => 2005-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 6728 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/820/07820637.pdf [firstpage_image] =>[orig_patent_app_number] => 11908697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5070185 [patent_doc_number] => 20070191287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'D-ribose for improving depression-like symptoms' [patent_app_type] => utility [patent_app_number] => 10/590986 [patent_app_country] => US [patent_app_date] => 2005-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5301 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191287.pdf [firstpage_image] =>[orig_patent_app_number] => 10590986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 650998 [patent_doc_number] => 07112575 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-09-26 [patent_title] => 'Energy-protective composition comprising adenosine phosphates' [patent_app_type] => utility [patent_app_number] => 11/076956 [patent_app_country] => US [patent_app_date] => 2005-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4730 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/112/07112575.pdf [firstpage_image] =>[orig_patent_app_number] => 11076956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7988031 [patent_doc_number] => 08076310 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-13 [patent_title] => 'Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production' [patent_app_type] => utility [patent_app_number] => 10/598535 [patent_app_country] => US [patent_app_date] => 2005-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 34844 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/076/08076310.pdf [firstpage_image] =>[orig_patent_app_number] => 10598535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6911777 [patent_doc_number] => 20050175535 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Myocardial perfusion imaging method' [patent_app_type] => utility [patent_app_number] => 11/070768 [patent_app_country] => US [patent_app_date] => 2005-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11520 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20050175535.pdf [firstpage_image] =>[orig_patent_app_number] => 11070768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14041 [patent_doc_number] => 07807821 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-10-05 [patent_title] => 'Method for the synthesis of nucleic acid without protecting base moiety' [patent_app_type] => utility [patent_app_number] => 10/591172 [patent_app_country] => US [patent_app_date] => 2005-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1863 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807821.pdf [firstpage_image] =>[orig_patent_app_number] => 10591172 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7257115 [patent_doc_number] => 20050143451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Use of parthenolide to inhibit cancer' [patent_app_type] => utility [patent_app_number] => 11/063144 [patent_app_country] => US [patent_app_date] => 2005-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9812 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20050143451.pdf [firstpage_image] =>[orig_patent_app_number] => 11063144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7192793 [patent_doc_number] => 20050163735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Use of high oleic high stearic oils' [patent_app_type] => utility [patent_app_number] => 11/060126 [patent_app_country] => US [patent_app_date] => 2005-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7365 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20050163735.pdf [firstpage_image] =>[orig_patent_app_number] => 11060126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 453460 [patent_doc_number] => 07247721 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-24 [patent_title] => 'Materials and methods for binding nucleic acids to surfaces' [patent_app_type] => utility [patent_app_number] => 11/057440 [patent_app_country] => US [patent_app_date] => 2005-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1723 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/247/07247721.pdf [firstpage_image] =>[orig_patent_app_number] => 11057440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5035325 [patent_doc_number] => 20070099864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'Use of o-atp for the treatment of diseases involving angiogenesis' [patent_app_type] => utility [patent_app_number] => 10/589621 [patent_app_country] => US [patent_app_date] => 2005-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1180 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20070099864.pdf [firstpage_image] =>[orig_patent_app_number] => 10589621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4652364 [patent_doc_number] => 20080039620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => '3\'-End Nucleoside Unit Comprising Phosphoramidite' [patent_app_type] => utility [patent_app_number] => 10/590268 [patent_app_country] => US [patent_app_date] => 2005-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4641 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20080039620.pdf [firstpage_image] =>[orig_patent_app_number] => 10590268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5673154 [patent_doc_number] => 20060178509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Phosphoramidite activator for oligonucleotide synthesis' [patent_app_type] => utility [patent_app_number] => 11/053733 [patent_app_country] => US [patent_app_date] => 2005-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5113 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20060178509.pdf [firstpage_image] =>[orig_patent_app_number] => 11053733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7187897 [patent_doc_number] => 20050192249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Room temperature stable agarose solutions' [patent_app_type] => utility [patent_app_number] => 11/050243 [patent_app_country] => US [patent_app_date] => 2005-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4215 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20050192249.pdf [firstpage_image] =>[orig_patent_app_number] => 11050243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 32973 [patent_doc_number] => 07785839 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-31 [patent_title] => 'Methods to manufacture 1,3-dioxolane nucleosides' [patent_app_type] => utility [patent_app_number] => 11/051287 [patent_app_country] => US [patent_app_date] => 2005-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 22 [patent_no_of_words] => 24276 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/785/07785839.pdf [firstpage_image] =>[orig_patent_app_number] => 11051287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14047 [patent_doc_number] => 07807823 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-05 [patent_title] => 'Method of forming polysaccharide structures' [patent_app_type] => utility [patent_app_number] => 11/050003 [patent_app_country] => US [patent_app_date] => 2005-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 8006 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 183 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807823.pdf [firstpage_image] =>[orig_patent_app_number] => 11050003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7005716 [patent_doc_number] => 20050171029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Methods and compositions for treating cancer' [patent_app_type] => utility [patent_app_number] => 11/045947 [patent_app_country] => US [patent_app_date] => 2005-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14523 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20050171029.pdf [firstpage_image] =>[orig_patent_app_number] => 11045947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5085859 [patent_doc_number] => 20070275910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Phosphoramidate Derivatives' [patent_app_type] => utility [patent_app_number] => 10/586101 [patent_app_country] => US [patent_app_date] => 2005-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7749 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20070275910.pdf [firstpage_image] =>[orig_patent_app_number] => 10586101 [rel_patent_id] =>[rel_patent_doc_number] =>)